USPTO 2015–2025 USPTO PatentsView US Corporation

Roche Diabetes Care, Inc.

USPTO PatentsView assignee record - 610 granted patents across 103 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

610

Total patents granted

103

CPC technology areas

17.2

Avg claims per patent

-14%

5-year filing velocity

The verdict

Roche holds 610 US patents across 103 technology areas, rank #750 of 50,000 tracked assignees.

#750
of 50,000 US assignees by volume: Top 3%
by Innovation Score (62.0/100): 17.2
avg claims per patent: -14%
filing velocity, last 5 yrs

Portfolio overview

Roche Diabetes Care, Inc. has been granted 610 US utility patents between 2015 and 2025, placing Roche Diabetes Care, Inc. at rank #750 across all assignees tracked by PlainPatent. This portfolio spans 103 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Roche Diabetes Care, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Roche sits between Ford Motor Company (612 patents, rank #746) and GE Aviation Systems Limited (607 patents, rank #754) - the closest US assignees by grant volume. The composite Innovation Score of 62.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 282 grants, compared with 328 in the 2015–2019 window, a -14% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Roche Diabetes Care, Inc.'s 17.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Roche Diabetes Care, Inc. against peers pursuing similar technology classes.

Ford Motor

612
Spectrum Brands

612
Yahoo Holdings

611
Renault S

610
SK Innovation

610
Roche Diabetes Ca… ◀

610
Oki Data

609
University of Uta…

608
GE Aviation Syste…

607

What this shows Roche holds 610 patents at rank #750, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Roche

By rank, the assignees closest to #750 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Roche's primary technology class.

Roche's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Roche Diabetes Care, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	33	5.4%
2016	84	13.8%
2017	60	9.8%
2018	70	11.5%
2019	81	13.3%
2020	61	10.0%
2021	60	9.8%
2022	54	8.9%
2023	37	6.1%
2024	44	7.2%
2025	26	4.3%

Which technologies does Roche Diabetes Care, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 306

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 202

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 173

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 147

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 63

G06F - ELECTRIC DIGITAL DATA PROCESSING 47

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 44

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 26

H04W - WIRELESS COMMUNICATION NETWORKS 23

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 23

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 16

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 14

G08B - SIGNALLING OR CALLING SYSTEMS; ORDER TELEGRAPHS; ALARM SYSTEMS 13

C12Y - ENZYMES 11

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 11

Top 15 of 103 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Diversified

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#750

Across all tracked assignees

Innovation Score

62.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Roche Diabetes Care, Inc. hold?

Roche Diabetes Care, Inc. holds 610 US granted patents filed between 2015 and 2025, spanning 103 technology areas.

What is Roche Diabetes Care, Inc.'s Innovation Score?

Roche Diabetes Care, Inc. has an Innovation Score of 62.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Roche Diabetes Care, Inc. focus on?

Roche Diabetes Care, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 306 patents. The company has filed patents in 103 CPC subclasses total.

Is Roche Diabetes Care, Inc.'s patent filing rate increasing or decreasing?

Roche Diabetes Care, Inc.'s recent filing velocity is -14% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Roche Diabetes Care, Inc.'s patents?

Roche Diabetes Care, Inc.'s patents average 17.2 claims each. This falls within the standard range, providing solid legal coverage.

How is the Roche Diabetes Care, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Roche's 610 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Roche ranks #750 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.